Xenetic Biosciences (XBIO) Invested Capital (2023 - 2025)
Xenetic Biosciences' Invested Capital history spans 6 years, with the latest figure at $7.4 million for Q4 2025.
- For Q4 2025, Invested Capital rose 23.12% year-over-year to $7.4 million; the TTM value through Dec 2025 reached $7.4 million, up 23.12%, while the annual FY2025 figure was $7.4 million, 23.12% up from the prior year.
- Invested Capital reached $7.4 million in Q4 2025 per XBIO's latest filing, up from $4.0 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $12.9 million in Q1 2023 to a low of $4.0 million in Q3 2025.
- Average Invested Capital over 3 years is $8.0 million, with a median of $7.4 million recorded in 2024.
- The largest YoY upside for Invested Capital was 23.12% in 2025 against a maximum downside of 43.78% in 2025.
- A 3-year view of Invested Capital shows it stood at $9.8 million in 2023, then plummeted by 38.67% to $6.0 million in 2024, then grew by 23.12% to $7.4 million in 2025.
- Per Business Quant, the three most recent readings for XBIO's Invested Capital are $7.4 million (Q4 2025), $4.0 million (Q3 2025), and $4.5 million (Q2 2025).